Xcout Intel
Magnolia Medical Technologies, Inc.
Magnolia Medical Technologies, Inc. is a medical device company headquartered in Seattle and Bellevue, Washington. The company develops diagnostic and blood collection technologies designed to reduce in-vitro diagnostic errors and improve blood culture accuracy.
Subscribe to see Magnolia Medical Technologies, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Magnolia Medical Technologies, Inc. at a glance
Magnolia Medical Technologies, Inc. is a medical technology company headquartered in United States. Its most recent funding round raised $43.4M in January 2022. Xcout tracks 12 named people at Magnolia Medical Technologies, Inc., including Jason Richey (President & Chief Executive Officer).
Magnolia Medical Technologies, Inc. leadership
- Jason RicheyPresident & Chief Executive Officer
- Erik BeuckelaersChief Financial Officer
- Gregory J. BullingtonCo-Founder
- Richard G. Patton, M.D.Co-Founder
- Sarah HuberSenior Vice President, Sales
- Carolyn DerubertisHead of Human Resources
6 more named people on record for Magnolia Medical Technologies, Inc., with roles, board committees and tenure — see the full roster →
Magnolia Medical Technologies, Inc. funding rounds
The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $43.4M | — | |
| Series C | $20M | — | |
| SEC Form D filing | $19.6M | — | |
| Series B | $21M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Magnolia Medical Technologies, Inc. competitors
A few of Magnolia Medical Technologies, Inc.'s closest competitors — see the full list of competitors and alternatives →
RedDrop Dx designs next-generation capillary sampling systems to provide virtually pain-free blood collection for healthcare providers, laboratories, and life science teams. Based in Fort Collins, Colorado, the company offers an FDA-cleared Class II blood sampling device that is automation-ready for clinical and at-home use.
Coagulo Medical Technologies is an MIT-born startup that has developed a precision-medicine platform for point-of-care diagnostics. Headquartered in Auburndale, Massachusetts, the company focuses on advancing healthcare technology.
Sysmex Astrego is a medical technology company specializing in automated antibiotic susceptibility testing to combat antimicrobial resistance.
Headquartered in Muttenz, Switzerland, Resistell AG is a biotechnology company incorporated in 2018 that develops rapid antibiotic susceptibility testing devices as an innovative alternative to traditional culture-based antibiograms.
Spot On Sciences is a life science company founded in 2010 and headquartered in San Francisco, California. The company develops and markets innovative, patented medical devices for biospecimen sampling.
Affinity Biosensors manufactures the LifeScale system, a medical technology product that provides rapid antimicrobial susceptibility testing (AST) results for gram-negative bacteria from positive blood cultures. The system uses population-profiling technology to deliver laboratory test results in approximately four hours to assist medical and laboratory professionals.
Get Magnolia Medical Technologies, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Magnolia Medical Technologies, Inc. in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- 7 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access